Investor's Champion share news, analysis and insight

Make your money go further for just 25p per day

PREMIUM
AIM IHT

Tariff impact | Well-placed | Big contract

27/05/2026 · BTG Consulting (BTG)  · Cohort (CHRT)  · CVS Group (CVSG)  · Hardide PLC (HDD)  · Michelmersh Brick (MBH)  · Nexteq (NXQ) 

AIM AIM Inheritance Tax potential Dividends UK

AI generated image of submarine sonar

News covered here includes our assessment of the latest update from a company well-placed to benefit from increased spending on defence. We consider whether all the good news is already baked into the current valuation or if there is more upside for investors. Elsewhere, US tariffs have impacted trading conditions for one business supplying technology products into the casino sector while a veterinary group appears to be addressing the concerns of an activist investor. Read on here for more on this and our usual forthright views on news from other small caps.


Nexteq: tariff impact hits the shares

Nexteq (AIM: NXQ), a technology solutions provider to customers in industrial markets, has announced that global geopolitical uncertainty is impacting its customer’s confidence.

In the Group's Quixant division, which serves the land-based gaming market (notably casinos), trading conditions have been impacted indirectly by US tariffs, and directly by higher costs for critical memory and storage components, which have increased their customers' prices to end markets. The Board…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

Sign-up to our free email updates

SIGN UP

Sign-up to our free email updates

SIGN UP